SRx Health Solutions Inc. (SRXH)
NYSEAMERICAN: SRXH · Real-Time Price · USD
0.2933
-0.0057 (-1.91%)
Aug 14, 2025, 9:30 AM - Market open
Company Description
SRx Health Solutions Inc. provides healthcare and medical treatment services.
It provides compounding services, pharmacy services, nursing healthcare, clinic services, vaccination services, caring for diabetes patients, travel health, compounding services, TB testing, and human immunodeficiency virus prevention services.
The company also operates retail-owned pharmacies. In addition, it provides COVID-19 testing services.
The company was founded in 2013 and is based in Toronto, Canada. It has additional locations in Canada and London, the United Kingdom.
SRx Health Solutions Inc.
| Country | Canada |
| Founded | 2013 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 470 |
| CEO | Kent Cunningham |
Contact Details
Address: 65 Queen St W , Unit 530 Toronto, ON M5H 2M5 Canada | |
| Phone | 844-577-9779 |
| Website | srxhealth.ca |
Stock Details
| Ticker Symbol | SRXH |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| CIK Code | 0001711786 |
| ISIN Number | US08771Y4026 |
Key Executives
| Name | Position |
|---|---|
| Kent Cunningham | Chief Executive Officer, President and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 12, 2025 | 10-Q | Quarterly Report |
| Aug 5, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 5, 2025 | 8-K | Current Report |
| Jun 24, 2025 | 8-K | Current Report |
| Jun 20, 2025 | 8-K | Current Report |
| Jun 16, 2025 | ARS | Filing |
| Jun 16, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 16, 2025 | DEF 14A | Other definitive proxy statements |
| Jun 9, 2025 | 8-K | Current Report |
| May 16, 2025 | 8-K | Current Report |